COVID-19 Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04VSI
|
|||
Drug Name |
Arbidol
|
|||
Synonyms |
Umifenovir; Arbidole; MC-101
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Coronavirus Disease 2019 (COVID-19) | Phase 2 | [1] | |
Other Indication | Influenza virus infection | Phase 4 | [2] | |
Therapeutic Class |
Antiviral Agents
|
|||
Company |
Good Earth Medicine
|
|||
Structure |
Download2D MOL |
|||
Formula |
C22H25BrN2O3S
|
|||
Canonical SMILES |
CCOC(=O)C1=C(N(C2=CC(=C(C(=C21)CN(C)C)O)Br)C)CSC3=CC=CC=C3
|
|||
InChI |
1S/C22H25BrN2O3S/c1-5-28-22(27)20-18(13-29-14-9-7-6-8-10-14)25(4)17-11-16(23)21(26)15(19(17)20)12-24(2)3/h6-11,26H,5,12-13H2,1-4H3
|
|||
InChIKey |
KCFYEAOKVJSACF-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 131707-25-0
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
ChEBI ID |
CHEBI:134730
|
References | Top | |||
---|---|---|---|---|
1 | ClinicalTrials.gov (NCT04260594) Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus | |||
2 | ClinicalTrials.gov (NCT01651663) A Study of Arbidol (Umifenovir) for Treatment and Prophylaxis of Influenza and Common Cold (ARBITR) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.